| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. | Director | Restricted Stock Units | 6,333 | $53,577 | $8.46 | 28 Mar 2025 | Direct |
| Avalo Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $14.35 | 14 Nov 2025 | Direct |
| Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16,400 | 14 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | 14 Nov 2025 | 4 | -$81,921 | 4 | Director | 17 Nov 2025, 16:05 |
| AVTX | Avalo Therapeutics, Inc. | 17 Jun 2025 | 1 | $0 | 4 | Director | 18 Jun 2025, 16:35 |
| AVTX | Avalo Therapeutics, Inc. | 28 Mar 2025 | 2 | $0 | 4 | Director | 01 Apr 2025, 16:55 |
| AVTX | Avalo Therapeutics, Inc. | 13 Aug 2024 | 2 | $0 | 4 | Director | 14 Aug 2024, 17:04 |
| AVTX | Avalo Therapeutics, Inc. | 27 Mar 2024 | 0 | $0 | 3 | Director | 03 Apr 2024, 16:04 |